Avenue Therapeutics Inc (ATXI)
2.01
0.00 (0.00%)
USD |
NASDAQ |
Nov 22, 16:00
2.01
0.00 (0.00%)
After-Hours: 20:00
Avenue Therapeutics Total Liabilities (Quarterly): 0.973M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.973M |
| June 30, 2024 | 1.161M |
| March 31, 2024 | 1.412M |
| December 31, 2023 | 1.196M |
| September 30, 2023 | 5.024M |
| June 30, 2023 | 7.812M |
| March 31, 2023 | 10.60M |
| December 31, 2022 | 3.579M |
| September 30, 2022 | 0.614M |
| June 30, 2022 | 0.407M |
| March 31, 2022 | 0.797M |
| December 31, 2021 | 0.509M |
| September 30, 2021 | 0.848M |
| June 30, 2021 | 0.549M |
| March 31, 2021 | 0.469M |
| December 31, 2020 | 0.886M |
| Date | Value |
|---|---|
| September 30, 2020 | 1.118M |
| June 30, 2020 | 1.23M |
| March 31, 2020 | 0.923M |
| December 31, 2019 | 2.115M |
| September 30, 2019 | 1.917M |
| June 30, 2019 | 1.773M |
| March 31, 2019 | 9.412M |
| December 31, 2018 | 5.156M |
| September 30, 2018 | 2.469M |
| June 30, 2018 | 4.419M |
| March 31, 2018 | 5.92M |
| December 31, 2017 | 2.79M |
| September 30, 2017 | 1.99M |
| June 30, 2017 | 7.549M |
| March 31, 2017 | 9.138M |
| December 31, 2016 | 8.445M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
0.407M
Minimum
Jun 2022
10.60M
Maximum
Mar 2023
2.111M
Average
1.046M
Median
Total Liabilities (Quarterly) Benchmarks
| Fortress Biotech Inc | 139.82M |
| NovaBay Pharmaceuticals Inc | 2.805M |
| Palatin Technologies Inc | 11.10M |
| iBio Inc | 6.763M |
| Theriva Biologics Inc | 15.47M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.625M |
| Shareholders Equity (Quarterly) | 2.61M |